FDA authorizes Novavax vaccine for kids ages 12-17 with Andrea Garcia, JD, MPH | COVID-19 Update

AMA's Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, shares news on the Novavax vaccine from the FDA—as well as updates on COVID boosters for fall, monkeypox vaccines, TPOXX treatments, and Dr. Anthony Fauci's announcement on stepping down from the National Institute of Allergy and Infectious Diseases (NIAID). American Medical Association CXO Todd Unger hosts.

0:00 AMA COVID-19 Update for August 24, 2022
0:30 COVID-19 case numbers are down 19% from two weeks ago
1:01 COVID hospitalizations and deaths are decreasing nationally
1:56 FDA authorized Novavax for emergency use in adolescents (12-17 years old) and for adults ages 18 and over
3:12 Novavax COVID vaccine trial data and findings
3:57 Fall booster shot news
5:20 Get second COVID booster now, if eligible
6:18 Monkeypox vaccines and treatments
7:15 More TPOXX doses available
8:02 Monkeypox cases in the U.S.
8:49 Dr. Fauci to leave NIAID